TherapeuticsMD (TXMD) Depreciation and Depletion (2010 - 2022)

TherapeuticsMD has reported Depreciation and Depletion for 13 years, with the latest figure at $200000.0 in Q4 2022.

• For the quarter ending Q4 2022, Depreciation and Depletion rose 200.0% year-over-year to $200000.0; the trailing twelve-month figure through Sep 2023 stood at $200000.0 (down 33.33% YoY), and the FY2022 full-year result was $600000.0, up 50.0% from the prior year.
• Depreciation and Depletion for Q4 2022 stood at $200000.0, roughly flat from $200000.0 in the prior quarter.
• The five-year high for Depreciation and Depletion was $200000.0 in Q2 2020, with the low at -$200000.0 in Q4 2021.
• Historically, Depreciation and Depletion has averaged $124020.6 across 5 years, with a median of $187625.0 in 2019.
• Annual changes were most pronounced in 2020 — Depreciation and Depletion soared 200.5% — and 2021, when it sank 200.0%.
• TherapeuticsMD's Depreciation and Depletion stood at $59989.0 in 2018, then jumped by 193.8% to $176250.0 in 2019, then rose by 13.48% to $200000.0 in 2020, then slumped by 200.0% to -$200000.0 in 2021, then surged by 200.0% to $200000.0 in 2022.
• The last three Depreciation and Depletion figures came in at $200000.0 (Q4 2022), $200000.0 (Q3 2022), and $200000.0 (Q2 2022), per Business Quant data.